July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vincent Rajkumar: CHMP Recommends Approval of New DARZALEX Indication for Smouldering Multiple Myeloma
Jun 22, 2025, 17:50

Vincent Rajkumar: CHMP Recommends Approval of New DARZALEX Indication for Smouldering Multiple Myeloma

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic, shared a post on X:

“Breaking: Big news for smoldering myeloma.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of a new indication for DARZALEX(daratumumab) subcutaneous (SC) formulation as monotherapy for the treatment of adult patients with smouldering multiple myeloma (SMM) at high-risk of developing multiple myeloma.

This is based on results of the AQUILA trial.

If approved, patients with high risk smoldering myeloma will have a choice that can delay progression to active myeloma and highly likely to prolong life.

More on the CHMP decision.

More posts featuring Vincent Rajkumar.